You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 12, September 24, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Pacemakers/ Defibrillators
 •Medical Practice
 •Medical Ethics
 •Cardiovascular System
 •Randomized Controlled Trial
 •Arrhythmias
 •Cardiovascular Intervention
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ethical Aspects in Trials of Implantable Medical Devices—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: We agree with Dr Heckerling that sham surgery can be ethical and often is necessary for the appropriate investigation of new surgical procedures. There is an important distinction, however, between sham surgery and the implantation of pacemakers for the purpose of controlling vasovagal syncope. Sham surgery implies that the intervention has no therapeutic potential. In our study, the control patients actually received a functional pacemaker, which was temporarily deactivated for the purpose of the study. At the time of initiation of our trial there was considerable evidence that pacemaker therapy was beneficial for the management of vasovagal syncope. In fact, the practice guidelines published by major organizations recommend the use of pacemaker therapy in this setting.1

Patients in our trial likely would have received a pacemaker for the management of their vasovagal syncope even if they had not been enrolled in the trial. Furthermore, the results of our . . . [Full Text of this Article]

Stuart J. Connolly, MD; Bruce L. Wilkoff, MD; Carlos Morillo, MD; Robert Sheldon, MD; Michael Gent, DSc; Robin S. Roberts, MTech; , MD Kenneth A. Ellenbogen for the VPS II Investigators



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Ethical Aspects in Trials of Implantable Medical Devices
Paul S. Heckerling
JAMA. 2003;290(12):1579.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.